Jyske Bank
19.1.2026 08:51:37 CET | Globenewswire | Press release
Share repurchase programme: Transactions of week 3 2026
Share repurchase programme: Transactions of week 3 2026
The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the "Safe Harbour Rules").
The following transactions have been made under the program:
| Number of shares | Average purchase price (DKK) | Transaction value (DKK) | |
| Accumulated, previous announcement | 3,130,478 | 665.93 | 2,084,679,517 |
| 12 January 2026 | 14,000 | 871.00 | 12,193,940 |
| 13 January 2026 | 13,872 | 883.77 | 12,259,714 |
| 14 January 2026 | 13,904 | 937.84 | 13,039,737 |
| 15 January 2026 | 13,000 | 946.54 | 12,305,024 |
| 16 January 2026 | 13,000 | 945.67 | 12,293,694 |
| Accumulated under the programme | 3,198,254 | 671.23 | 2,146,771,627 |
Following settlement of the transactions stated above, Jyske Bank will own a total of 3,198,254 of treasury shares, excluding investments made on behalf of customers and shares held for trading purposes, corresponding to 5.20% of the share capital.
Attached to this corporate announcement, aggregated details on the transactions related to the share repurchase programme are shown by venue.
Yours faithfully,
Jyske Bank
Contact: Birger Krøgh Nielsen, CFO, tel. +45 89 89 64 44
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Octave Intelligence plc19.8.2026 17:19:02 CEST | Press release
Director/PDMR Shareholding
The Metals Company19.8.2026 16:25:19 CEST | Press release
NOAA Publishes TMC USA’s Consolidated Application for an Exploration License and Commercial Recovery Permit for TMC USA-A in the Federal Register
Shufti Pro Limited19.8.2026 16:00:00 CEST | Press release
Shufti Helps Obliged Entities Get Ready for the EU AMLR Ahead of the July 2027 Deadline
Cosmos Health Inc.19.8.2026 15:00:00 CEST | Press release
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
Teva Pharmaceutical Industries Ltd19.8.2026 14:30:00 CEST | Press release
U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom